Samantha L. Eaton
Edinburgh, SCT EH259RG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
AAV-delivered PPT1 provides long-term neurological benefits in CLN1 mice and achieves therapeutic levels in sheep brain.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 04, 2025
Haploinsufficiency of lysosomal enzyme genes in Alzheimer's disease.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024
Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex.
Journal: Acta neuropathologica communications
Published: September 29, 2022
Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation.
Journal: Aging cell
Published: September 08, 2022
An Optimized Comparative Proteomic Approach as a Tool in Neurodegenerative Disease Research.
Journal: Cells
Published: July 20, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep.
Journal: The Journal of clinical investigation
Published: June 29, 2022
The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo.
Journal: The FEBS journal
Published: November 08, 2021
Training associated alterations in equine respiratory immunity using a multiomics comparative approach.
Journal: Scientific reports
Published: August 06, 2021
Pre-natal manifestation of systemic developmental abnormalities in spinal muscular atrophy.
Journal: Human molecular genetics
Published: June 05, 2020
Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease.
Journal: Scientific reports
Published: January 15, 2020
Last Updated: 09/26/2026